Follow up Study to Assess Long Term Safety and Outcomes in Infants and Children Born to Mothers Participating in Retosiban Treatment Studies

NCT02292784 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

98

Enrollment

INDUSTRY

Sponsor class

Conditions

Obstetric Labour, Premature

Interventions

DRUG: Retosiban
DRUG: Atosiban
DRUG: Placebo

Sponsor

GlaxoSmithKline

Collaborators

[object Object]